These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10389145)

  • 21. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
    Sesia T; Bizup B; Grace AA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1295-307. PubMed ID: 23360787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats.
    de Haas R; Nijdam A; Westra TA; Kas MJ; Westenberg HG
    J Psychopharmacol; 2011 Dec; 25(12):1712-9. PubMed ID: 21148023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B
    Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
    Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW
    Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis.
    de Haas R; Seddik A; Oppelaar H; Westenberg HG; Kas MJ
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):657-63. PubMed ID: 22326620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Orexin Receptor Antagonism on Quinpirole-Induced Compulsive-Like Checking Behavior in Rats.
    Abounoori M; Maddah MM; Akbari E; Houshmand G; Ardeshiri MR
    Neurotox Res; 2020 Jun; 38(1):18-26. PubMed ID: 32207079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age differences in an animal model of obsessive-compulsive disorder: participation of dopamine: dopamine in an animal model of OCD.
    Ulloa RE; Nicolini H; Fernández-Guasti A
    Pharmacol Biochem Behav; 2004 Aug; 78(4):661-6. PubMed ID: 15301919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.
    Korff S; Stein DJ; Harvey BH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):348-55. PubMed ID: 17888556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
    Tizabi Y; Louis VA; Taylor CT; Waxman D; Culver KE; Szechtman H
    Biol Psychiatry; 2002 Jan; 51(2):164-71. PubMed ID: 11822995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
    Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
    Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats.
    Mundt A; Klein J; Joel D; Heinz A; Djodari-Irani A; Harnack D; Kupsch A; Orawa H; Juckel G; Morgenstern R; Winter C
    Eur J Neurosci; 2009 Jun; 29(12):2401-12. PubMed ID: 19490027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional MRI of altered brain development in a novel adolescent rat model of quinpirole-induced compulsive checking behavior.
    Straathof M; Blezer ELA; van Heijningen C; Smeele CE; van der Toorn A; ; Buitelaar JK; Glennon JC; Otte WM; Dijkhuizen RM
    Eur Neuropsychopharmacol; 2020 Apr; 33():58-70. PubMed ID: 32151497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Lactobacillus casei Consumption in Improvement of Obsessive-Compulsive Disorder: an Animal Study.
    Sanikhani NS; Modarressi MH; Jafari P; Vousooghi N; Shafei S; Akbariqomi M; Heidari R; Lavasani PS; Yazarlou F; Motevaseli E; Ghafouri-Fard S
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1409-1419. PubMed ID: 32124236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrafreeloading in Rats Is Adaptive and Flexible: Support for an Animal Model of Compulsive Checking.
    Frederick MJ; Cocuzzo SE
    Evol Psychol; 2017; 15(4):1474704917735937. PubMed ID: 29073770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D
    Egashira N; Kubota N; Goto Y; Watanabe T; Kubota K; Katsurabayashi S; Iwasaki K
    Pharmacol Biochem Behav; 2018 Feb; 165():9-13. PubMed ID: 29273456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA; Velez LP; Masten VL; Dulawa SC
    Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis].
    Okamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(1):36-44. PubMed ID: 21404630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.